レンチウイルスベクターの世界市場レポート 2025年

レンチウイルスベクターの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR15.3％で294億1,000万米ドルに成長します。予測期間の成長は、個別化医療の成長、遺伝子編集イノベーション、希少疾患治療需要、レンチウイルスベクター採用、ゲノム医療資金調達、製造スケーラビリティ重視に起因します。予測期間における主な動向としては、研究開発の拡大、CAR-T細胞療法への統合、次世代ベクターの開発、ワクチン開発への採用、生産技術の開発などが挙げられます。

慢性疾患の有病率の上昇がレンチウイルスベクター市場の成長を牽引すると予想されます。慢性疾患は、徐々に発症し、何年も、あるいは生涯にわたって持続する長期的な健康状態です。これらの疾患の有病率の増加は、人口の高齢化、不健康なライフスタイル、都市化、環境の影響などの要因に起因しています。レンチウイルスベクターは、慢性疾患に対するワクチンや治療戦略を開発し、アンメット・メディカル・ニーズに対応し、患者の転帰を改善するための、多用途で効率的なツールを提供します。例えば、2024年9月、英国を拠点とする心臓血管研究の慈善団体である英国心臓財団（British Heart Foundation）は、英国では約760万人が心臓・循環器系疾患に罹患しており、男性400万人、女性360万人がこれらの疾患を抱えていると報告しました。これらの病気は英国における全死亡の約27％を占め、年間17万人以上、1日当たり約480人、つまりおよそ3分に1人の死亡につながっています。このように、慢性疾患の有病率の増加がレンチウイルスベクター市場の成長を牽引しています。

レンチウイルスベクター市場の主要プレーヤーは、細胞ベースの免疫腫瘍学治療のためのレンチウイルスベクター製造の効率性と堅牢性を高めるために、LVベクター製造プラットフォームの進歩に力を注いでいます。そのような革新的なプラットフォームの一つがLentiSureであり、細胞ベースの免疫腫瘍学治療用のレンチウイルスベクターの製造を最適化するように設計されています。2023年5月にYposkesi sk pharmtecoによって発表されたLentiSureは、細胞・遺伝子治療におけるスケーラブルで信頼性の高いウイルスベクター製造技術に対する需要の高まりに対応し、レンチウイルス製造の弾力性と効率性を強化することを目的としています。LentiSureは、安定した製品品質と高い生産性といった特徴を持ち、細胞ベースの免疫腫瘍学的療法の開発と商業化を加速し、慢性疾患に関連するアンメット・メディカル・ニーズに対応することが期待されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界レンチウイルスベクターPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のレンチウイルスベクター市場：成長率分析
• 世界のレンチウイルスベクター市場の実績：規模と成長, 2019-2024
• 世界のレンチウイルスベクター市場の予測：規模と成長, 2024-2029, 2034F
• 世界レンチウイルスベクター総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のレンチウイルスベクター市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キット
• 試薬および消耗品
• 世界のレンチウイルスベクター市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 遺伝性疾患
• 感染症
• 獣医疾患
• その他の適応症
• 世界のレンチウイルスベクター市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジー企業
• 製薬会社
• 調査業務受託機関（CRO）
• 学術研究機関
• 世界のレンチウイルスベクター市場、キットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レンチウイルス導入キット
• レンチウイルスパッケージングキット
• レンチウイルスベクター制作キット
• 世界のレンチウイルスベクター市場、試薬および消耗品の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レンチウイルスパッケージング試薬
• レンチウイルスベクター濃縮試薬
• レンチウイルスベクター用トランスフェクション試薬

第7章 地域別・国別分析

• 世界のレンチウイルスベクター市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のレンチウイルスベクター市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• レンチウイルスベクター市場：競合情勢
• レンチウイルスベクター市場：企業プロファイル
  • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc（GSK）
• Eli Lilly and Company
• Agilent Technologies Inc
• Amgen Inc
• Merck KGaA
• Lonza Group Ag
• Cytiva
• Charles River Laboratories
• Bio-Rad Laboratories Inc
• Promega Corporation
• Takara Bio Inc
• Sino Biological Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• レンチウイルスベクター市場2029：新たな機会を提供する国
• レンチウイルスベクター市場2029：新たな機会を提供するセグメント
• レンチウイルスベクター市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A lentiviral vector is a viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of host cells. These vectors are widely used in molecular biology and gene therapy applications to deliver genetic material into target cells for purposes such as gene expression, gene silencing, or genetic modification.

Key products in the lentiviral vector category include kits, reagents, and consumables. Lentiviral vector kits provide a comprehensive set of tools and components necessary for generating and manipulating lentiviral vectors. These kits find application across various indications such as cancer, genetic disorders, infectious diseases, veterinary diseases, and more. Users of lentiviral vector products include biotechnology companies, pharmaceutical companies, contract research organizations (CROs), as well as academic and research institutes.

The lentiviral vector market research report is one of a series of new reports from The Business Research Company that provides lentiviral vector market statistics, including lentiviral vector industry global market size, regional shares, competitors with a lentiviral vector market share, detailed lentiviral vector market segments, market trends and opportunities, and any further data you may need to thrive in the lentiviral vector industry. This lentiviral vector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lentiviral vector market size has grown rapidly in recent years. It will grow from $14.37 billion in 2024 to $16.62 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to prevalence of genetic disorders, gene delivery demand, biotech and pharma expansion, clinical trial investment, regulatory approvals.

The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $29.41 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to personalized medicine growth, gene editing innovations, rare disease therapy demand, lentiviral vector adoption, genomic medicine funding, manufacturing scalability focus. Major trends in the forecast period include expansion of research and development, integration in CAR-T cell therapy, development of next-generation vectors, adoption in vaccine development, development of production technologies.

The rising prevalence of chronic diseases is expected to drive the growth of the lentiviral vectors market. Chronic diseases are long-term health conditions that develop gradually and persist for years or even a lifetime. The increasing prevalence of these diseases is attributed to factors such as aging populations, unhealthy lifestyles, urbanization, and environmental influences. Lentiviral vectors provide versatile and efficient tools for developing vaccines and treatment strategies for chronic diseases, addressing unmet medical needs and improving patient outcomes. For instance, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases are responsible for around 27% of all deaths in the UK, leading to over 170,000 deaths annually, or about 480 deaths per day-roughly one death every three minutes. Thus, the increasing prevalence of chronic diseases is driving the growth of the lentiviral vectors market.

Key players in the lentiviral vectors market are concentrating their efforts on advancing LV vector production platforms to enhance the efficiency and robustness of lentivirus vector manufacturing for cell-based immuno-oncology therapies. One such innovative platform is LentiSure, designed to optimize the production of lentiviral vectors for cell-based immuno-oncology therapies. Launched by Yposkesi sk pharmteco in May 2023, LentiSure aims to bolster the resilience and efficiency of lentivirus production, catering to the escalating demand for scalable and reliable viral vector manufacturing technologies in cell and gene therapies. With features such as consistent product quality and high productivity, LentiSure offers promise in accelerating the development and commercialization of cell-based immuno-oncology therapies, addressing the unmet medical needs associated with chronic diseases.

In September 2024, Kyverna Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, entered into a license and supply agreement for the LentiVector platform with Oxford Biomedica. This collaboration allows Kyverna to utilize Oxford Biomedica's proprietary lentiviral vector technology in the development of gene therapies, particularly targeting autoimmune diseases. The agreement supports the expansion and innovation of the lentiviral vector market by ensuring a scalable and reliable supply of vectors to meet the growing demand. Oxford Biomedica is a UK-based biotechnology company specializing in providing lentiviral vector platforms.

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lentiviral vector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lentiviral vector market consists of sales of 3rd generation lentiviral vectors, Lenti-ORF clones, and lentiviral particles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lentiviral Vector Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lentiviral vector market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lentiviral vector ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lentiviral vector market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits; Reagents And Consumables
• 2) By Indication: Cancer; Genetic Disorder; Infectious Disease; Veterinary Disease; Other Indications
• 3) By End User: Biotechnology Companies; Pharmaceutical Companies; Contract Research Organization (CRO); Academic And Research Institutes
• Subsegments:
• 1) By Kits: Lentiviral Transduction Kits; Lentiviral Packaging Kits; Lentiviral Vector Production Kits
• 2) By Reagents and Consumables: Lentiviral Packaging Reagents; Lentiviral Vector Concentration Reagents; Transfection Reagents for Lentiviral Vectors
• Companies Mentioned: Pfizer Inc; AbbVie Inc; Bayer AG; Sanofi SA; Bristol Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lentiviral Vector Market Characteristics

3. Lentiviral Vector Market Trends And Strategies

4. Lentiviral Vector Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Lentiviral Vector Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lentiviral Vector PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lentiviral Vector Market Growth Rate Analysis
• 5.4. Global Lentiviral Vector Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lentiviral Vector Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lentiviral Vector Total Addressable Market (TAM)

6. Lentiviral Vector Market Segmentation

• 6.1. Global Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Reagents And Consumables
• 6.2. Global Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Genetic Disorder
• Infectious Disease
• Veterinary Disease
• Other Indications
• 6.3. Global Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organization (CRO)
• Academic And Research Institutes
• 6.4. Global Lentiviral Vector Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lentiviral Transduction Kits
• Lentiviral Packaging Kits
• Lentiviral Vector Production Kits
• 6.5. Global Lentiviral Vector Market, Sub-Segmentation Of Reagents and Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lentiviral Packaging Reagents
• Lentiviral Vector Concentration Reagents
• Transfection Reagents for Lentiviral Vectors

7. Lentiviral Vector Market Regional And Country Analysis

• 7.1. Global Lentiviral Vector Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lentiviral Vector Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lentiviral Vector Market

• 8.1. Asia-Pacific Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lentiviral Vector Market

• 9.1. China Lentiviral Vector Market Overview
• 9.2. China Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lentiviral Vector Market

• 10.1. India Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lentiviral Vector Market

• 11.1. Japan Lentiviral Vector Market Overview
• 11.2. Japan Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lentiviral Vector Market

• 12.1. Australia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lentiviral Vector Market

• 13.1. Indonesia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lentiviral Vector Market

• 14.1. South Korea Lentiviral Vector Market Overview
• 14.2. South Korea Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lentiviral Vector Market

• 15.1. Western Europe Lentiviral Vector Market Overview
• 15.2. Western Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lentiviral Vector Market

• 16.1. UK Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lentiviral Vector Market

• 17.1. Germany Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lentiviral Vector Market

• 18.1. France Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lentiviral Vector Market

• 19.1. Italy Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lentiviral Vector Market

• 20.1. Spain Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lentiviral Vector Market

• 21.1. Eastern Europe Lentiviral Vector Market Overview
• 21.2. Eastern Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lentiviral Vector Market

• 22.1. Russia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lentiviral Vector Market

• 23.1. North America Lentiviral Vector Market Overview
• 23.2. North America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lentiviral Vector Market

• 24.1. USA Lentiviral Vector Market Overview
• 24.2. USA Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lentiviral Vector Market

• 25.1. Canada Lentiviral Vector Market Overview
• 25.2. Canada Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lentiviral Vector Market

• 26.1. South America Lentiviral Vector Market Overview
• 26.2. South America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lentiviral Vector Market

• 27.1. Brazil Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lentiviral Vector Market

• 28.1. Middle East Lentiviral Vector Market Overview
• 28.2. Middle East Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lentiviral Vector Market

• 29.1. Africa Lentiviral Vector Market Overview
• 29.2. Africa Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lentiviral Vector Market Competitive Landscape And Company Profiles

• 30.1. Lentiviral Vector Market Competitive Landscape
• 30.2. Lentiviral Vector Market Company Profiles
  • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Lentiviral Vector Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc
• 31.2. AstraZeneca plc
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc (GSK)
• 31.5. Eli Lilly and Company
• 31.6. Agilent Technologies Inc
• 31.7. Amgen Inc
• 31.8. Merck KGaA
• 31.9. Lonza Group Ag
• 31.10. Cytiva
• 31.11. Charles River Laboratories
• 31.12. Bio-Rad Laboratories Inc
• 31.13. Promega Corporation
• 31.14. Takara Bio Inc
• 31.15. Sino Biological Inc

32. Global Lentiviral Vector Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lentiviral Vector Market

34. Recent Developments In The Lentiviral Vector Market

35. Lentiviral Vector Market High Potential Countries, Segments and Strategies

• 35.1 Lentiviral Vector Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lentiviral Vector Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lentiviral Vector Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer